Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection.
Nakabori T, Abe Y, Higashi S, Hirao T, Kawamoto Y, Maeda S, Daiku K, Urabe M, Kai Y, Takada R, Yamai T, Ikezawa K, Uehara H, Ohkawa K.
Nakabori T, et al. Among authors: ohkawa k.
JGH Open. 2022 Apr 22;6(5):309-316. doi: 10.1002/jgh3.12737. eCollection 2022 May.
JGH Open. 2022.
PMID: 35601125
Free PMC article.